Concepedia

F 11356, a Novel 5-Hydroxytryptamine (5-HT) Derivative with Potent, Selective, and Unique High Intrinsic Activity at 5-HT1B/1D Receptors in Models Relevant to Migraine

Gareth W. John, Petrus J. Pauwels, Michel Perez, Serge Halazy, Bruno Le Grand, Yvan Verscheure, Jean-Pierre Valentin, Christiane Palmier, Thierry Wurch, Philippe Chopin,

Journal of Pharmacology and Experimental Therapeutics · 1999 · 38 citations · 45 references

DOI

Concepts

References

45

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

J E Leysen, C. J. E. Niemegeers, Jan M. Van Nueten et al. · Molecular Pharmacology · 1982 · 1.1K citations

, , +17

Pharmacologic Analysis of Drug Receptor Interaction

Kenakin. T. Kenakin · Therapeutic Drug Monitoring · 1988 · 930 citations

, , +17

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Frederick J. Monsma, Yong Shen, Raymond P. Ward et al. · Molecular Pharmacology · 1993 · 598 citations · Full text

, , +17

Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

Yiping Shen, Frederick J. Monsma, Mark A. Metcalf et al. · Journal of Biological Chemistry · 1993 · 509 citations · Full text

, , +17

Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs

Antoinette MaassenVanDenBrink, Marije Reekers, Willem A. Bax et al. · Circulation · 1998 · 327 citations · Full text

, , +16